Flynn AA - Search Results

1

Clinical applications of phage-derived sFvs and sFv fusion proteins.

Chester KA, Bhatia J, Boxer G, Cooke SP, Flynn AA, Huhalov A, Mayer A, Pedley RB, Robson L, Sharma SK, Spencer DI, Begent RH. Chester KA, et al. Among authors: flynn aa. Dis Markers. 2000;16(1-2):53-62. doi: 10.1155/2000/672706. Dis Markers. 2000. PMID: 11360829 Free PMC article. Review.

2

Recombinant anti-carcinoembryonic antigen antibodies for targeting cancer.

Chester KA, Mayer A, Bhatia J, Robson L, Spencer DI, Cooke SP, Flynn AA, Sharma SK, Boxer G, Pedley RB, Begent RH. Chester KA, et al. Among authors: flynn aa. Cancer Chemother Pharmacol. 2000;46 Suppl:S8-12. doi: 10.1007/pl00014055. Cancer Chemother Pharmacol. 2000. PMID: 10950140 Review.

3

Radioimmunoluminography: a tool for relating tissue antigen concentration to clinical outcome.

Boxer G, Stuart-Smith S, Flynn A, Green A, Begent R. Boxer G, et al. Br J Cancer. 1999 May;80(5-6):922-6. doi: 10.1038/sj.bjc.6690443. Br J Cancer. 1999. PMID: 10360677 Free PMC article.

4

A novel technique, using radioluminography, for the measurement of uniformity of radiolabelled antibody distribution in a colorectal cancer xenograft model.

Flynn AA, Green AJ, Boxer GM, Casey JL, Pedley RB, Begent RH. Flynn AA, et al. Int J Radiat Oncol Biol Phys. 1999 Jan 1;43(1):183-9. doi: 10.1016/s0360-3016(98)00275-2. Int J Radiat Oncol Biol Phys. 1999. PMID: 9989525

5

Taking engineered anti-CEA antibodies to the clinic.

Mayer A, Chester KA, Flynn AA, Begent RH. Mayer A, et al. Among authors: flynn aa. J Immunol Methods. 1999 Dec 10;231(1-2):261-73. doi: 10.1016/s0022-1759(99)00162-3. J Immunol Methods. 1999. PMID: 10648943 Review.

6

Radioimmunoguided surgery in colorectal cancer using a genetically engineered anti-CEA single-chain Fv antibody.

Mayer A, Tsiompanou E, O'Malley D, Boxer GM, Bhatia J, Flynn AA, Chester KA, Davidson BR, Lewis AA, Winslet MC, Dhillon AP, Hilson AJ, Begent RH. Mayer A, et al. Among authors: flynn aa. Clin Cancer Res. 2000 May;6(5):1711-9. Clin Cancer Res. 2000. PMID: 10815889 Clinical Trial.

7

Relationship between tumour morphology, antigen and antibody distribution measured by fusion of digital phosphor and photographic images.

Flynn AA, Boxer GM, Begent RH, Pedley RB. Flynn AA, et al. Cancer Immunol Immunother. 2001 Apr;50(2):77-81. doi: 10.1007/s002620100176. Cancer Immunol Immunother. 2001. PMID: 11401028 Free PMC article.

8

Eradication of colorectal xenografts by combined radioimmunotherapy and combretastatin a-4 3-O-phosphate.

Pedley RB, Hill SA, Boxer GM, Flynn AA, Boden R, Watson R, Dearling J, Chaplin DJ, Begent RH. Pedley RB, et al. Among authors: flynn aa. Cancer Res. 2001 Jun 15;61(12):4716-22. Cancer Res. 2001. PMID: 11406542

9

Optimizing radioimmunotherapy by matching dose distribution with tumor structure using 3D reconstructions of serial images.

Flynn AA, Pedley RB, Green AJ, Boxer GM, Boden R, Begent RH. Flynn AA, et al. Cancer Biother Radiopharm. 2001 Oct;16(5):391-400. doi: 10.1089/108497801753354294. Cancer Biother Radiopharm. 2001. PMID: 11776756

10

Synergy between vascular targeting agents and antibody-directed therapy.

Pedley RB, El-Emir E, Flynn AA, Boxer GM, Dearling J, Raleigh JA, Hill SA, Stuart S, Motha R, Begent RH. Pedley RB, et al. Among authors: flynn aa. Int J Radiat Oncol Biol Phys. 2002 Dec 1;54(5):1524-31. doi: 10.1016/s0360-3016(02)03923-8. Int J Radiat Oncol Biol Phys. 2002. PMID: 12459381

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

38 results

Search Page